Gilteritinib
Products Gilteritinib was approved in the form of film-coated tablets in the United States in 2018, in the EU in 2019, and in many countries in 2020 (Xospata). Structure and properties Gilteritinib (C29H44N8O3, Mr = 552.7 g/mol) is present in the drug as gilteritinib fumarate, a light yellow to yellow powder or crystals that are … Gilteritinib
